ACUTE MIGRAINE
Clinical trials for ACUTE MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MIGRAINE trials appear
Sign up with your email to follow new studies for ACUTE MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Migraine drug tested for Long-Term safety in 1,000-Person trial
Symptom relief Not yet recruitingThis phase 3 study evaluates the long-term safety of elismetrep (K-304), an oral medication taken as needed for migraine attacks. About 1,000 adults who previously took elismetrep in an earlier trial will continue using it intermittently. Researchers will track side effects over …
Matched conditions: ACUTE MIGRAINE
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New migraine sprays and tablets tested in ER for quick relief
Symptom relief Not yet recruitingThis study will test two FDA-approved migraine drugs, rimegepant (a tablet that dissolves on the tongue) and zavegepant (a nasal spray), in 100 adults visiting the emergency department for a migraine. The goal is to see if these drugs provide pain relief within 2 hours without ne…
Matched conditions: ACUTE MIGRAINE
Phase: PHASE1 • Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC